Do analysts prefer THCX or ACB?

Aurora Cannabis has a consensus target price of C$7.17, suggesting a potential upside of 75.22%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hydropothecary 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has stronger earnings and valuation, THCX or ACB?

Hydropothecary has higher earnings, but lower revenue than Aurora Cannabis. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hydropothecary N/A N/A N/A N/A N/A Aurora Cannabis C$320.59M 0.79 -C$44.16M -C$2.14 N/A

Which has preferable valuation and earnings, GUD or ACB?

Knight Therapeutics has higher revenue and earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Knight Therapeutics C$510.45M 1.91 -C$30.73M C$0.06 165.17 Aurora Cannabis C$320.59M 0.79 -C$44.16M -C$2.14 N/A

Which has better earnings & valuation, TLRY or ACB?

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tilray Brands C$858.28M 0.94 -C$183.24M -C$14.63 N/A Aurora Cannabis C$320.59M 0.79 -C$44.16M -C$2.14 N/A

Which has preferable earnings & valuation, WEED or ACB?

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Canopy Growth C$284.60M 2.11 -C$1.05B -C$0.88 N/A Aurora Cannabis C$320.59M 0.79 -C$44.16M -C$2.14 N/A

Aurora Cannabis (ACB) Competitors

C$4.09 +0.04 (+0.99%)

As of 07/3/2026 04:00 PM Eastern

Compare

ACB vs. DHT.UN, THCX, GUD, TLRY, and WEED

Should you buy Aurora Cannabis stock or one of its competitors? MarketBeat compares Aurora Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aurora Cannabis include DRI Healthcare Trust (DHT.UN), Hydropothecary (THCX), Knight Therapeutics (GUD), Tilray Brands (TLRY), and Canopy Growth (WEED). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Aurora Cannabis compare to DRI Healthcare Trust?

DRI Healthcare Trust (TSE:DHT.UN) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

DRI Healthcare Trust has a net margin of 5.02% compared to Aurora Cannabis' net margin of -12.13%. DRI Healthcare Trust's return on equity of 2.06% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DRI Healthcare Trust	5.02%	2.06%	4.22%
Aurora Cannabis	-12.13%	-7.25%	-1.87%

DRI Healthcare Trust presently has a consensus price target of C$24.80, indicating a potential upside of 28.36%. Aurora Cannabis has a consensus price target of C$7.17, indicating a potential upside of 75.22%. Given Aurora Cannabis' higher probable upside, analysts plainly believe Aurora Cannabis is more favorable than DRI Healthcare Trust.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

DRI Healthcare Trust has a beta of 0.385191, suggesting that its share price is 61% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.174133, suggesting that its share price is 83% less volatile than the broader market.

In the previous week, DRI Healthcare Trust had 3 more articles in the media than Aurora Cannabis. MarketBeat recorded 4 mentions for DRI Healthcare Trust and 1 mentions for Aurora Cannabis. DRI Healthcare Trust's average media sentiment score of 0.75 beat Aurora Cannabis' score of -1.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company	Overall Sentiment
DRI Healthcare Trust	Positive
Aurora Cannabis	Negative

0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.1% of Aurora Cannabis shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DRI Healthcare Trust has higher earnings, but lower revenue than Aurora Cannabis. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DRI Healthcare Trust	C$163.77M	6.49	C$9.73M	-C$0.90	N/A
Aurora Cannabis	C$320.59M	0.79	-C$44.16M	-C$2.14	N/A

Summary

DRI Healthcare Trust beats Aurora Cannabis on 13 of the 17 factors compared between the two stocks.

How does Aurora Cannabis compare to Hydropothecary?

Hydropothecary (CVE:THCX) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

4.1% of Aurora Cannabis shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -12.13%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hydropothecary	N/A	N/A	N/A
Aurora Cannabis	-12.13%	-7.25%	-1.87%

In the previous week, Aurora Cannabis had 1 more articles in the media than Hydropothecary. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Hydropothecary. Hydropothecary's average media sentiment score of 0.00 beat Aurora Cannabis' score of -1.00 indicating that Hydropothecary is being referred to more favorably in the media.

Company	Overall Sentiment
Hydropothecary	Neutral
Aurora Cannabis	Negative

Hydropothecary has higher earnings, but lower revenue than Aurora Cannabis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hydropothecary	N/A	N/A	N/A	N/A	N/A
Aurora Cannabis	C$320.59M	0.79	-C$44.16M	-C$2.14	N/A

Aurora Cannabis has a consensus target price of C$7.17, suggesting a potential upside of 75.22%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hydropothecary	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Aurora Cannabis beats Hydropothecary on 6 of the 10 factors compared between the two stocks.

How does Aurora Cannabis compare to Knight Therapeutics?

Knight Therapeutics (TSE:GUD) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

Knight Therapeutics presently has a consensus price target of C$9.50, indicating a potential downside of 4.14%. Aurora Cannabis has a consensus price target of C$7.17, indicating a potential upside of 75.22%. Given Aurora Cannabis' higher possible upside, analysts plainly believe Aurora Cannabis is more favorable than Knight Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Knight Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

23.6% of Knight Therapeutics shares are owned by institutional investors. Comparatively, 4.1% of Aurora Cannabis shares are owned by institutional investors. 45.6% of Knight Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Knight Therapeutics has a beta of -0.206788, indicating that its share price is 121% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.174133, indicating that its share price is 83% less volatile than the broader market.

Knight Therapeutics has higher revenue and earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Knight Therapeutics	C$510.45M	1.91	-C$30.73M	C$0.06	165.17
Aurora Cannabis	C$320.59M	0.79	-C$44.16M	-C$2.14	N/A

Knight Therapeutics has a net margin of 1.10% compared to Aurora Cannabis' net margin of -12.13%. Knight Therapeutics' return on equity of 0.73% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Knight Therapeutics	1.10%	0.73%	0.51%
Aurora Cannabis	-12.13%	-7.25%	-1.87%

In the previous week, Aurora Cannabis had 1 more articles in the media than Knight Therapeutics. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Knight Therapeutics. Knight Therapeutics' average media sentiment score of 0.00 beat Aurora Cannabis' score of -1.00 indicating that Knight Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Knight Therapeutics	Neutral
Aurora Cannabis	Negative

Summary

Knight Therapeutics beats Aurora Cannabis on 11 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to Tilray Brands?

Tilray Brands (TSE:TLRY) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

Tilray Brands presently has a consensus price target of C$13.30, indicating a potential upside of 103.99%. Aurora Cannabis has a consensus price target of C$7.17, indicating a potential upside of 75.22%. Given Tilray Brands' higher probable upside, equities analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

4.1% of Tilray Brands shares are owned by institutional investors. Comparatively, 4.1% of Aurora Cannabis shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Aurora Cannabis has a net margin of -12.13% compared to Tilray Brands' net margin of -158.75%. Aurora Cannabis' return on equity of -7.25% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Aurora Cannabis	-12.13%	-7.25%	-1.87%

In the previous week, Tilray Brands and Tilray Brands both had 1 articles in the media. Tilray Brands' average media sentiment score of 0.00 beat Aurora Cannabis' score of -1.00 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Overall Sentiment
Tilray Brands	Neutral
Aurora Cannabis	Negative

Tilray Brands has a beta of 3.0845, meaning that its stock price is 208% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.174133, meaning that its stock price is 83% less volatile than the broader market.

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.94	-C$183.24M	-C$14.63	N/A
Aurora Cannabis	C$320.59M	0.79	-C$44.16M	-C$2.14	N/A

Summary

Tilray Brands beats Aurora Cannabis on 8 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to Canopy Growth?

Canopy Growth (TSE:WEED) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings and profitability.

Canopy Growth has a beta of 1.44612, indicating that its stock price is 45% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.174133, indicating that its stock price is 83% less volatile than the broader market.

4.3% of Canopy Growth shares are held by institutional investors. Comparatively, 4.1% of Aurora Cannabis shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Canopy Growth currently has a consensus price target of C$1.88, indicating a potential upside of 32.04%. Aurora Cannabis has a consensus price target of C$7.17, indicating a potential upside of 75.22%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts plainly believe Aurora Cannabis is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Aurora Cannabis had 1 more articles in the media than Canopy Growth. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.00 beat Aurora Cannabis' score of -1.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Neutral
Aurora Cannabis	Negative

Aurora Cannabis has a net margin of -12.13% compared to Canopy Growth's net margin of -84.76%. Aurora Cannabis' return on equity of -7.25% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-84.76%	-35.48%	-3.83%
Aurora Cannabis	-12.13%	-7.25%	-1.87%

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	C$284.60M	2.11	-C$1.05B	-C$0.88	N/A
Aurora Cannabis	C$320.59M	0.79	-C$44.16M	-C$2.14	N/A

Summary

Aurora Cannabis beats Canopy Growth on 9 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACB vs. The Competition

Export

Metric	Aurora Cannabis	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$253.34M	C$6.60B	C$7.18B	C$13.07B
Dividend Yield	N/A	2.83%	2.67%	6.18%
P/E Ratio	-1.91	5.11	28.02	36.51
Price / Sales	0.79	1,653.39	534.82	10.34
Price / Cash	1.25	10.18	49.26	82.29
Price / Book	0.46	10.83	10.96	4.52
Net Income	-C$44.16M	C$20.27B	C$3.57B	C$299.09M
7 Day Performance	0.99%	1.30%	2.12%	1.85%
1 Month Performance	-12.98%	-1.17%	5.25%	1.71%
1 Year Performance	-34.14%	9.82%	33.29%	36.40%

Aurora Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACB Aurora Cannabis	2.1036 of 5 stars	C$4.09 +1.0%	C$7.17 +75.2%	-34.1%	C$253.34M	C$320.59M	N/A	1,073	Negative News Analyst Forecast
DHT.UN DRI Healthcare Trust	3.3135 of 5 stars	C$17.47 -0.8%	C$25.50 +46.0%	+44.5%	C$961.13M	C$163.77M	N/A	N/A	News Coverage Dividend Announcement Ex-Dividend Analyst Forecast
THCX Hydropothecary	N/A	C$5.30 +6.6%	N/A	+0.0%	C$949.11M	N/A	N/A	N/A	High Trading Volume
GUD Knight Therapeutics	N/A	C$9.23 -0.9%	C$9.50 +2.9%	+63.8%	C$906.19M	C$510.45M	153.83	725
TLRY Tilray Brands	1.1232 of 5 stars	C$6.56 +0.6%	C$13.30 +102.7%	-2.7%	C$792.57M	C$858.28M	N/A	2,650

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:ACB) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aurora Cannabis (ACB) Competitors

ACB vs. DHT.UN, THCX, GUD, TLRY, and WEED

How does Aurora Cannabis compare to DRI Healthcare Trust?

Summary

How does Aurora Cannabis compare to Hydropothecary?

Summary

How does Aurora Cannabis compare to Knight Therapeutics?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Summary

How does Aurora Cannabis compare to Canopy Growth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aurora Cannabis (ACB) Competitors

ACB vs. DHT.UN, THCX, GUD, TLRY, and WEED

How does Aurora Cannabis compare to DRI Healthcare Trust?

Is DHT.UN or ACB more profitable?

Do analysts prefer DHT.UN or ACB?

Which has more risk and volatility, DHT.UN or ACB?

Does the media prefer DHT.UN or ACB?

Do institutionals and insiders believe in DHT.UN or ACB?

Which has preferable earnings and valuation, DHT.UN or ACB?

Summary

How does Aurora Cannabis compare to Hydropothecary?

Do institutionals and insiders have more ownership in THCX or ACB?

Is THCX or ACB more profitable?

Does the media prefer THCX or ACB?

Which has stronger earnings and valuation, THCX or ACB?

Do analysts prefer THCX or ACB?

Summary

How does Aurora Cannabis compare to Knight Therapeutics?

Do analysts rate GUD or ACB?

Do institutionals and insiders believe in GUD or ACB?

Which has more volatility & risk, GUD or ACB?

Which has preferable valuation and earnings, GUD or ACB?

Is GUD or ACB more profitable?

Does the media refer more to GUD or ACB?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Do analysts rate TLRY or ACB?

Do institutionals & insiders have more ownership in TLRY or ACB?

Is TLRY or ACB more profitable?

Does the media refer more to TLRY or ACB?

Which has more risk and volatility, TLRY or ACB?

Which has better earnings & valuation, TLRY or ACB?

Summary

How does Aurora Cannabis compare to Canopy Growth?

Which has more volatility and risk, WEED or ACB?

Do insiders and institutionals have more ownership in WEED or ACB?

Do analysts prefer WEED or ACB?

Does the media refer more to WEED or ACB?

Is WEED or ACB more profitable?

Which has preferable earnings & valuation, WEED or ACB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools